Beauty fad’s ugly downside:
test interference

LabCorp is taking steps to make clinicians aware of the potential for biotin interference in immunoassays, says André Valcour, PhD, director of the Esoteric Immunoassay, Allergy, Coagulation, Toxicology, and Biological Monitoring departments at LabCorp’s Center for Esoteric Testing, Burlington, NC. “We are being proactive to get the issue out in the forefront.”

Read the full story »

Dr. André Valcour

As diabetic CKD takes toll,
work on tests continues

“Those of us in nephrology, we proportionally take care of more people with diabetes than most endocrinologists,” said Katherine Tuttle, MD, executive director for research, Providence Health Care, Spokane, Wash. “There are proportionally more diabetic patients in the nephrology clinic and dialysis centers than there are in the endocrine clinics. That’s a sobering fact.”

Read the full story »

Dr. Katherine Tuttle

Quizzed in Ansbach, then key to a drug trial for mast cell disease

In December 2007, American hematopathologist Tracy I. George, MD, who is currently a professor of pathology, division chief of hematopathology, and vice chair of clinical affairs at the University of New Mexico, spent a weekend in the small town of Ansbach in central Bavaria in the laboratory of Hans-Peter Horny, MD, whom she calls “the father of mast cell pathology.”

Read the full story »

Dr. Tracy I. George

Method or test?
Providing clarity to clinicians on NGS

Pathologists and laboratory professionals tend to think of NGS as a methodology, whereas their colleagues in clinical practice often view it as a test, says John D. Pfeifer, MD, PhD, vice chair for clinical affairs in pathology and immunology and a professor of pathology and immunology and of obstetrics and gynecology at Washington University School of Medicine.

Read the full story »

Dr. John D. Pfeifer

This Month’s Issue

Read, save, and print articles from the current issue

Articles

Chronological index
2013–2016

Product Guides

Compare all instruments
and software systems

Departments

Chronological index
2013–2015

Marketplace

New pathology lab products and industry news

Magazine Issue Archive

» 2013–2016 article index
»
2000–2012 article index

CAP TODAY Hosted Webinars

» Assessing the clinical genome: thoughts and lessons for improving diagnostic tests
»
All on-demand webinars

Product Guides

» Compare products side-by-side
»
Download product guide PDFs

Quick Links

» Subscribe or renew CAP TODAY
»
Search for jobs / Post open positions

CAP TODAY Recommends

Learn about molecular testing for M. pneumoniae

Donna Mayne, the microbiology, serology, and molecular laboratory manager at Sacred Heart Health System in Pensacola, Fla., outlines the clinical benefits of using molecular technology to detect Mycoplasma pneumoniae in a free program provided by Meridian Bioscience. Watch.

In a separate presentation, Vicki Chalker, PhD, head of the respiratory and vaccine-preventable bacteria reference unit of Public Health England’s National Infection Service, discusses the importance of testing for M. pneumoniae and the diagnostic methodologies available. Meridian’s M. pneumoniae test recently landed FDA clearance. Watch.

How pathologists can lead in value-based care

Pathologists have an opportunity to thrive and be health care team leaders in the coming world of accountable and value-based care, Donald Karcher, MD, argues in a webinar that offers a sneak peek of a course that he will moderate at CAP16 in Las Vegas. View the free, 30-minute webinar (registration required).

The CPOE Lab Test: Utilization Opportunity

This editorial is brought to you through Roche’s Lab Leaders initiative.

The future of the lab in health care

CAP TODAY publisher Bob McGonnagle gathered with Orchard Software executives to discuss what lies ahead for laboratories.

» More CAP TODAY Recommends